Recce Pharmaceuticals Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 10, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	126	84	122	111	158	162
Market Cap Growth	26.17%	-31.67%	9.86%	-29.54%	-2.17%	77.27%
Enterprise Value	126	86	121	110	142	138
Last Close Price	0.43	0.29	0.59	0.61	0.87	0.91
PS Ratio	129.08	11.14	24.34	25.52	51.25	98.70
PB Ratio	-6.76	-27.40	-12.85	-43.03	15.71	7.88
P/TBV Ratio	-	-	-	-	15.71	7.88
EV/Sales Ratio	129.53	11.51	24.03	25.13	46.16	84.42
Debt / Equity Ratio	-0.04	-3.53	-1.10	-1.27	0.01	0.01
Net Debt / Equity Ratio	-0.02	-0.03	-0.64	-0.67	-1.14	-1.01
Net Debt / EBITDA Ratio	-0.01	0.00	-0.36	-0.13	1.20	1.55
Net Debt / FCF Ratio	-0.02	0.00	-0.46	-0.14	1.27	2.62
Asset Turnover	0.31	0.80	1.13	0.57	0.18	0.13
Quick Ratio	0.03	1.78	0.30	0.34	4.81	19.59
Current Ratio	0.08	1.86	0.34	0.40	4.98	19.64
Return on Equity (ROE)	-	-	-	-350.01%	-71.89%	-118.45%
Return on Assets (ROA)	-581.01%	-135.80%	-238.05%	-106.04%	-35.15%	-67.74%
Return on Capital Employed (ROCE)	309.80%	-324.70%	195.40%	561.40%	-94.80%	-65.60%
Earnings Yield	-24.05%	-25.62%	-14.43%	-11.74%	-6.95%	-8.36%
FCF Yield	-18.32%	-24.48%	-10.75%	-11.42%	-5.72%	-4.91%
Buyback Yield / Dilution	-36.61%	-33.81%	-1.79%	0.09%	-12.05%	-22.17%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.